• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Johnson & Johnson rolls out next-gen intraocular lens

Johnson & Johnson rolls out next-gen intraocular lens

September 30, 2024 By Sean Whooley

Johnson & Johnson Tecnis Oddysey intraocular lens IOL
[Image courtesy of Johnson & Johnson]
Johnson & Johnson (NYSE: JNJ) announced today that it expanded the rollout of its latest Tecnis Odyssey presbyopia-correcting intraocular lenses (PC-IOLs).

The new full visual range IOL offers a continuous, full range of vision, enabling sight from far, near and in between. It minimzes the need for glasses for those with presbyiopia, according to a news relesae.

J&J built the IOL on its existing Tecnis platform. The company said it provides two-times better contrast in low lighting compared to the Alcon PanOptix IOL. It also touts the ability for patients to read 14% smaller print on average compared to PanOptix users. Additionally, 93% of users reported zero or mild halos, glare or starbursts one month after surgery.

The company said it built Tecnis Odyssey with proprietary technology that results in superior image quality. It delivers sharp vision even in challenging lighting conditions, plus fewer visual disturbances. Johnson & Johnson says 94% of patients reported satisfaction with their overall vision without glasses.

Additionally, 96% of patients reported satisfaction with reading a smartphone or tablet and 97% were satisfied with distance vision. The company reports 92% satisfaction with the ability to see steps at night and read street signs at night.

“More than 14,000 eyes have already benefited from Tecnis Odyssey, our new full visual range IOL. Tecnis Odyssey patients have reported outstanding visual outcomes following surgery, which is why we are excited to announce we are expanding the roll-out across the U.S. today,” said Peter Menziuso, group chair, Vision, J&J. “Cataract surgery gives patients a once in a lifetime opportunity to improve their sight, and now with this advanced IOL, patients can see clearly at every distance, without the need for glasses.”

Filed Under: Business/Financial News, Featured, Implants, Optical/Ophthalmic, Vision Tagged With: Johnson & Johnson, Johnson & Johnson MedTech

More recent news

  • Medtronic announces a company president
  • Medtronic nets CE mark for Vitalis family of conduction system pacemakers
  • E2’s pulmonary embolism platform claims two FDA clearances
  • Resmed to launch AirTouch F40 full-face fabric CPAP mask in US
  • Paradromics taps Siemens Healthineers to develop scalable BCI imaging

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy